An inverse factor analysis of 880 depressed inpatients on 33 endogenous-neurotic variables yielded four patient types. Type 3 resembled the endogenous depressions and Type 2 the neurotic depressions. Type 3 patients responded well to both imipramine and chlorpromazine and did poorly on a placebo. Type 2 patients showed the greatest overall improvement at three weeks irrespective of treatment received, including a placebo.
No takes yet. Share an insight, caveat, or question.
Raskin et al. (1976) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: